نتایج جستجو برای: biomarker validation

تعداد نتایج: 227799  

2004
Yuji Imafuku Gilbert S. Omenn Samir Hanash

The identification of autoantibodies to tumor cell proteins by proteomics approaches has great potential impact on cancer biomarker discovery. The humoral immune response represents a form of biological amplification of signals that are otherwise weak due to very low concentrations of antigen, especially in the early stages of cancers. In addition, proteomics can detect immunoreactivity directe...

2016
Heidrun Gevensleben Emily Eva Holmes Diane Goltz Jörn Dietrich Verena Sailer Jörg Ellinger Dimo Dietrich Glen Kristiansen

BACKGROUND The rapid development of programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors has generated an urgent need for biomarkers assisting the selection of patients eligible for therapy. The use of PD-L1 immunohistochemistry, which has been suggested as a predictive biomarker, however, is confounded by multiple unresolved issues. The aim of this study therefore was to quan...

Journal: :Oncology reports 2014
Ming Li Qian Zhang Liang Wu Chengyou Jia Fuhua Shi Shaocai Li Aimei Peng Guoliang Zhang Xiaolian Song Changhui Wang

The aim of the present study was to determine whether serum miR-499 may be used as a biomarker for early detection of non-small cell lung cancer (NSCLC). The present study was designed as an initial screening phase and a subsequent validation phase. In the screening phase, we analyzed serum levels of miR-499 in a subset of 40 patients with stage I (n=20) and stage IV (n=20) NSCLC. In the valida...

2017
Fu-Sheng Ouyang Bao-Liang Guo Bin Zhang Yu-Hao Dong Lu Zhang Xiao-Kai Mo Wen-Hui Huang Shui-Xing Zhang Qiu-Gen Hu

There is no consensus on specific prognostic biomarkers potentially improving survival of nasopharyngeal carcinoma (NPC), especially in advanced-stage disease. The prognostic value of MRI-based radiomics signature is unclear. A total of 970 quantitative features were extracted from the tumor of 100 untreated NPC patients (stage III-IVb) (discovery set: n = 70, validation set: n = 30). We then a...

Journal: :American journal of respiratory and critical care medicine 2013
Edward F Patz Michael J Campa Elizabeth B Gottlin Priscilla R Trotter James E Herndon Don Kafader Russell P Grant Marcia Eisenberg

RATIONALE Indeterminate pulmonary nodules are a common radiographic finding and require further evaluation because of the concern for lung cancer. OBJECTIVES We developed an algorithm to assign patients to a low- or high-risk category for lung cancer, based on a combination of serum biomarker levels and nodule size. METHODS For the serum biomarker assay, we determined levels of carcinoembry...

Journal: :Endocrine-related cancer 2005
F M Brouwers E F Petricoin L Ksinantova J Breza V Rajapakse S Ross D Johann M Mannelli B L Shulkin R Kvetnansky G Eisenhofer M M Walther B A Hitt T P Conrads T D Veenstra D P Mannion M R Wall G M Wolfe V A Fusaro L A Liotta K Pacak

Metastatic lesions occur in up to 36% of patients with pheochromocytoma. Currently there is no way to reliably detect or predict which patients are at risk for metastatic pheochromocytoma. Thus, the discovery of biomarkers that could distinguish patients with benign disease from those with metastatic disease would be of great clinical value. Using surface-enhanced laser desorption ionization pr...

2015
Fenja M Feld Philipp D Nagel Stephanie E Weissinger Claudia Welke Albrecht Stenzinger Peter Möller Jochen K Lennerz

Prognostication in pancreatic ductal adenocarcinoma (PDAC) remains a challenge. Recently, a link between mutated KRAS and glutamic-oxaloacetic transaminase (GOT1/AST1) has been described as part of the metabolic reprogramming in PDAC. The clinical relevance of this novel metabolic KRAS-GOT1 link has not been determined in primary human patient samples. Here we studied the GOT1 expression status...

2015
Hector R. Wong Natalie Z. Cvijanovich Nick Anas Geoffrey L. Allen Neal J. Thomas Michael T. Bigham Scott L. Weiss Julie Fitzgerald Paul A. Checchia Keith Meyer Michael Quasney Mark Hall Rainer Gedeit Robert J. Freishtat Jeffrey Nowak Shekhar S. Raj Shira Gertz Kelli Howard Kelli Harmon Patrick Lahni Erin Frank Kimberly W. Hart Christopher J. Lindsell

The temporal version of the pediatric sepsis biomarker risk model (tPERSEVERE) estimates the risk of a complicated course in children with septic shock based on biomarker changes from days 1 to 3 of septic shock. We validated tPERSEVERE performance in a prospective cohort, with an a priori plan to redesign tPERSEVERE if it did not perform well. Biomarkers were measured in the validation cohort ...

2017
Yi-Wei Xu Can-Tong Liu Xin-Yi Huang Li-Sheng Huang Yu-Hao Luo Chao-Qun Hong Hai-Peng Guo Li-Yan Xu Yu-Hui Peng En-Min Li

Esophageal squamous cell carcinoma (ESCC) remains one of the leading causes of cancer-related mortality around the world. The identification of novel serum biomarkers is required for early detection of ESCC. This study was designed to elucidate whether autoantibodies against STIP1 could be a diagnostic biomarker in ESCC. An enzyme-linked immunosorbent assay was performed to detect serum levels ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Xiaochen Wang Xiyong Liu Angela Ying-Jian Li Lirong Chen Lily Lai Her Helen Lin Shuya Hu Lifang Yao Jiaping Peng Sofia Loera Lijun Xue Bingsen Zhou Lun Zhou Shu Zheng Peiguo Chu Suzhan Zhang David Kong Ann Yun Yen

PURPOSE This study aims to address the hypothesis that the high-mobility group A2 (HMGA2), an oncofetal protein, relates to survivability and serves as a prognostic biomarker for colorectal cancer (CRC). EXPERIMENTAL DESIGN This is a retroprospective multiple center study. The HMGA2 expression level was determined by performing immunohistochemistry on surgical tissue samples of 89 CRCs from a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید